Lp(a) for Professionals


Lp(a) is a genetic independent risk factor for cardiovascular disease.

An estimated 20% to 30% of people worldwide have high levels of plasma lipoprotein(a).

It is important for clinicians to incorporate comprehensive guidelines for diagnosing, treating, and managing elevated Lp(a) into patient evaluation and risk assessment.

White and red blood cells in 3D Illustration

Lipoprotein(a): ASCVD Risk Factor That Can No Longer Be Ignored

Friday, May 3, 2024, at 10:00 AM Central

Join us to hear leading experts discuss genetics and the importance of measuring Lp(a) levels, as well as comprehensive clinical recommendations to incorporate patient-centered care for those with elevated Lp(a).

Older African American male patient sitting female doctor while the doctor takes notes

Toolkits

Lp(a) and Peripheral Artery Disease: Emerging Diagnosis and Management

PAD patients should be screened for elevated Lp(a) if they have a family history of atherosclerotic CVD or recurrence of major adverse limb events despite optimal medical therapy. Learn more about Lp(a) and PAD in this toolkit for health care professionals.

Lp(a) PAD Toolkit Cover Page
Healthcare Professional Toolkit Cover

Lp(a): A Toolkit for Healthcare Professionals

Elevated Lp(a) is associated with heightened risk for myocardial infarction, peripheral artery disease, stroke, and calcific aortic valve disease. Learn more in this toolkit for healthcare professionals.

Videos On Demand

Address gaps in your knowledge about Lipoprotein(a) and LDL-C. Watch these evidence-based on demand videos to learn the latest science and gain expert insights into incorporating the measurement of Lp(a) into patient evaluation and risk assessment. CE and MOC available. 

Lp(a) in Clinical Practice:

Guidelines & Special Populations

Lipoprotein(a)

The Science Behind the Risk Factor

W.O.W.

Why hOw and When to measure Lipoprotein(a): A Clinically Relevant Cardiovascular Risk Factor

Approaches to Identification

Approaches to identification and management of patients with increased LDL-C and Lp(a)

Lp(a) Patient Education Resources

Talking to patients about their Lp(a) levels can help reduce their risk of heart disease. Check out these free downloadable Patient Education Resources to use in conversation with your patients:

Patient and doctor talking

Guidelines-on-the-Go

Photo of female healthcare professional looking at a smart phone. Banner says, "Guidelines On The Go, AHA science at your fingertips"

The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.